Levetiracetam

Type: Product

Name: Levetiracetam

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Switch to generic can sometimes be problematic

Q: I have epilepsy and was well-controlled on Keppra and Topamax for years. When I was switched to generic Keppra (levetiracetam) without realizing it, I had several seizures in two weeks. I fell down stairs and had a seizure while cooking.My doctor has ... [Published Baltimore Sun - May 23 2013]

Entities: Tinea cruris, Vitamin D, Levetiracetam

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Levetiracetam

LEVETIRACETAM (Levetiracetam) Solution [Orit Laboratories LLC]

Updated Date: May 22, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 22 2013]

Entities: Levetiracetam

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Unexplained Crying Spells in a 2-Year-Old

A 24-month-old boy with congenital limb deformities, refractory epilepsy, gastroesophageal reflux disease (GERD), chronic constipation and developmental delay presented to the neurology clinic for investigation of severe "screaming spells" that had been ... [Published Advance for NPs and PAs - May 17 2013]

Entities: Epilepsy, Seizures, Levetiracetam

First reported May 17 2013 - Updated May 17 2013 - 1 reports

UCB SA

UCB and IBM bet on big data to help epilepsy

UCB has teamed up with IBM to "harness super-computer power" and help improve treatment for epilepsy patients.The partners have announced the completion of the initial phase of a "pioneering project designed to harness the power of super computers and ... [Published Pharma Times - May 17 2013]

Entities: Epilepsy, UCB SA, IBM Corp, Big Data

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Sun Pharmaceutical Industries Ltd

Pharmaceuticals Newsletter - 06 May to 09 May, 2013

Sun Pharma Advanced Research Company Ltd announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for Levetiracetam Extended-release Tablets, 1000mg and 1500mg, an anti-epileptic ... [Published India Infoline - May 09 2013]

Entities: Levetiracetam, complete response, Sun Pharmaceutical Industries Ltd, New Drug Application

First reported May 05 2013 - Updated May 06 2013 - 7 reports

FDA Food & Drug Administration

SPARC gets US FDA response on Levetiracetam NDA

SPARC is evaluating the contents of the letter and plans further discussions with the FDASun Pharma Advanced Research Company (SPARC) announced receipt of a complete response Letter from the US Food and Drug Administration (FDA) on its New Drug Application ... [Published Express Pharma - May 06 2013]

Entities: FDA Food & Drug Administration, Levetiracetam, New Drug Application

First reported May 05 2013 - Updated May 05 2013 - 1 reports

SpiceJet Ltd

Stocks to watch: Sun Pharma, Balaji Tele and SpiceJet

Sun Pharma Advance may lose sparkThe stock of Sun Pharma Advance Research Co (SPARC) may come under pressure this week as the US authority rejected its new drug application for an anti-epileptic product. The USFDA said that it cannot approve the Levetiracetam ... [Published Hindu Business Line - May 05 2013]

Entities: SpiceJet Ltd, Sun Pharmaceutical Industries Ltd, Balaji Telefilms Ltd

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

One vehicle crash sends driver to jail

MARTIN COUNTY — Saturday at approximately 1:35 p.m. the Martin County Dispatch Center received a call of a possible personal injury traffic accident on SR 550 at Abel Hill Road involving a Silver Ford Focus.Martin County Dispatch also received information ... [Published Washington Times-Herald - Apr 30 2013]

Entities: Ford Focus, Controlled Substance, Silver, prison

First reported Apr 25 2013 - Updated Apr 25 2013 - 4 reports

UCB Sales Drop in 1Q - Analyst Blog

UCB ( UCBJF ) recently reported results for the first quarter of 2013. Revenues fell 8.2% year over year to approximately $1.1 billion due to generic erosion of Keppra and a delayed allergy season.All growth rates mentioned below are on a year-on-year ... [Published Nasdaq - Apr 25 2013]

Entities: UCB SA, Rotigotine, Lacosamide, Levetiracetam

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

UCB suffers as cold weather delays hay fever season

Belgian drugmaker UCBhad a difficult first quarter as cold spring weather inEurope meant fewer hay fever sufferers were buying its allergymedicines, it said on Thursday.Its revenues for the quarter slipped 9 percent to 799 million euros ($1.04 billion) ... [Published Reuters - Apr 25 2013]

Entities: UCB SA, Levetiracetam, Levocetirizine, Zyrtec

First reported Mar 13 2013 - Updated Mar 13 2013 - 2 reports

IntelliPharmaCeutics receives Keppra application filing

IntelliPharmaCeutics International Inc. has provided an update on its generic versions of the marketed drugs Keppra XR and Pristiq. In September of 2012, the company announced that it had filed with the U.S. Food and Drug Administration two abbreviated ... [Published Stockwatch - Mar 13 2013]

Entities: Levetiracetam, Intellipharmaceutics Intl, Pristiq

First reported Mar 13 2013 - Updated Mar 13 2013 - 1 reports

LEVETIRACETAM LEVETIRACETAM (Levetiracetam) Solution [Camber Pharmaceuticals, Inc.]

Updated Date: Mar 13, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 13 2013]

Entities: Levetiracetam

Quotes

...We recently received this advice from a pharmacist: "You must ask your physician to complete a letter of medical necessity that documents how long the physician has been treating the patient, what therapies have been used and failed, and what therapies are working with minimal side effects."

Switch to generic can sometimes be problematic [Published Baltimore Sun - May 23 2013]

...He added that the collaboration "could benefit patients, their families and the healthcare system in a unique way"

UCB and IBM bet on big data to help epilepsy [Published Pharma Times - May 17 2013]

...of 2013 shows solid growth of our core medicines, Cimzia®, Vimpat® and Neupro® as well as in emerging markets", said Roch Doliveux, CEO of UCB. "At the same time as we are facing the remaining post exclusivity impacts on Keppra® we are facing strong seasonal effects due to the continued cold winter, affecting our allergy franchise. We are pleased with our pipeline performance, which includes positive phase 3 results in the U S with Vimpat® to treat epilepsy in monotherapy and a new project joining our pipeline - tozadenant in Parkinsons' disease."

UCB : Slow Start but Outlook 2013 and Growth Prospects Confirmed [Published 4 Traders - Apr 25 2013]

More Content

sort by: Date \| Relevance
Switch to generic can sometimes be problematic [Published Baltimore Sun - May 23 2013]
LEVETIRACETAM (Levetiracetam) Solution [Orit La... [Published DailyMed Drug Label Updates for the last seven ... - May 22 2013]
Unexplained Crying Spells in a 2-Year-Old [Published Advance for NPs and PAs - May 17 2013]
UCB and IBM bet on big data to help epilepsy [Published Pharma Times - May 17 2013]
Pharmaceuticals Newsletter - 06 May to 09 May, ... [Published India Infoline - May 09 2013]
UCB, Inc. - Pharmaceuticals & Healthcare - Deal... [Published TransWorldNews - May 08 2013]
SPARC gets US FDA response on Levetiracetam NDA [Published Express Pharma - May 06 2013]
SPARC dips as FDA rejects Levetiracetam NDA [Published Business Standard India - May 06 2013]
US FDA rejects SPARC's Levetiracetam NDA [Published PharmaBiz - May 06 2013]
SPARC receives negative response from USFDA on ... [Published Indian-Commodity - May 06 2013]
Sun Pharma gets USFDA response on Levetiracetam... [Published India Infoline - May 06 2013]
Sun Pharma Advanced Research Co Ltd Receives US... [Published Reuters - May 06 2013]
Sun Pharma Advanced Research Company receives U... [Published Equity Bulls - May 05 2013]
Stocks to watch: Sun Pharma, Balaji Tele and Sp... [Published Hindu Business Line - May 05 2013]
One vehicle crash sends driver to jail [Published Washington Times-Herald - Apr 30 2013]
UCB Sales Drop in 1Q - Analyst Blog [Published Nasdaq - Apr 25 2013]
UCB Sales Drop in 1Q - Analyst Blog [Published Quote.com Japan - Apr 25 2013]
UCB Sales Drop in 1Q Zacks [Published Yahoo! Finance - Apr 25 2013]
UCB suffers as cold weather delays hay fever se... [Published Reuters - Apr 25 2013]
UCB : Slow Start but Outlook 2013 and Growth Pr... [Published 4 Traders - Apr 25 2013]
IntelliPharmaCeutics loses $1.34-million (U.S.)... [Published Stockwatch - Apr 03 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Apr 02 2013]
Research and Markets: PharmaPoint: Epilepsy - I... [Published Business Wire Health News - Mar 20 2013]
Research and Markets: PharmaPoint: Epilepsy - J... [Published Business Wire Health News - Mar 19 2013]
IntelliPharmaCeutics receives Keppra applicatio... [Published Stockwatch - Mar 13 2013]
Intellipharmaceutics Announces Update on Its Ge... [Published GlobeNewswire: Acquisitions News - Mar 13 2013]
Intellipharmaceutics Announces Update on Its Ge... [Published Stockwatch - Mar 13 2013]
LEVETIRACETAM LEVETIRACETAM (Levetiracetam) Sol... [Published DailyMed Drug Label Updates for the last seven ... - Mar 13 2013]
Research and Markets: Trobalt/Potiga (Epilepsy)... [Published Yahoo! Finance - Mar 13 2013]
Research and Markets: Zebinix (Epilepsy) - Fore... [Published Yahoo! Finance - Mar 13 2013]